REED KENNETH enters REDHILL BIOPHARMA LTD. with 105.20M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001178913-26-001290
105.20M
Baseline shares
100% direct
105.20M
Direct ownership
1 position
26.32M
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned105.20M
Total
105.20M direct105.20M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 105.20M | Direct |
| Total | 105.20M | 105.20M direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
250K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
90K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
150K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
American Depositary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
25.83M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
26.32M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 250K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 90K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 150K | N/A | |
| American Depositary Shares Direct | Ordinary Shares | — | — | 25.83M | N/A | |
| Total | 26.32M | 0.00 | ||||